BTCC / BTCC Square / Global Cryptocurrency /
Hims & Hers (HIMS) Stock Surges 44% on Novo Nordisk Partnership for Weight-Loss Drugs

Hims & Hers (HIMS) Stock Surges 44% on Novo Nordisk Partnership for Weight-Loss Drugs

Published:
2026-03-09 09:57:02
19
1
BTCCSquare news:

Hims & Hers Health (HIMS) saw its stock skyrocket over 44% in premarket trading following reports of a groundbreaking partnership with Novo Nordisk to distribute weight-loss medications. The deal, expected to be announced imminently, marks a dramatic reversal from their legal dispute earlier this year when Novo sued Hims over alleged copycat versions of its Wegovy pill.

Analysts view this as a watershed moment for HIMS. Leerink's Michael Cherny called it "both a surprise and an unabashed positive," while Morgan Stanley's Craig Hettenbach noted it could alleviate regulatory pressures on the heavily shorted stock. The news propelled HIMS from its 51% year-to-date decline into one of Monday's biggest market movers.

The collaboration represents a strategic pivot for Novo Nordisk as it seeks broader distribution channels for its blockbuster obesity treatments. For Hims, the partnership validates its telehealth platform as a legitimate conduit for pharmaceutical giants—a development that could reshape digital health economics.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.